Christopher Ogden Cytom X Therapeutics, Inc. (CTMX) insider trading activity
Christopher Ogden is Chief Financial Officer of CytomX Therapeutics, Inc.. Currently has a direct ownership of 226,271 shares of CTMX, which is worth approximately $538,524. The most recent transaction as insider was on Jun 16, 2025, when has been sold 10,614 shares (Common Stock) at a price of $2.69 per share, resulting in proceeds of $28,551. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
226K
12.56%
3M change
119.28%
12M change
Total Value Held
$538,524
Christopher Ogden Transaction History
CO
Christopher Ogden
Chief Financial Officer
South San Francisco, CA